Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial.
Publication
, Journal Article
Gockerman, JP; Raney, M; Logan, T
Published in: Cancer Treat Rep
September 1985
Duke Scholars
Published In
Cancer Treat Rep
ISSN
0361-5960
Publication Date
September 1985
Volume
69
Issue
9
Start / End Page
1029 / 1030
Location
United States
Related Subject Headings
- Neutropenia
- Neoplasm Metastasis
- Nausea
- Naphthacenes
- Middle Aged
- Humans
- Female
- Drug Evaluation
- Breast Neoplasms
- Antibiotics, Antineoplastic
Citation
APA
Chicago
ICMJE
MLA
NLM
Gockerman, J. P., Raney, M., & Logan, T. (1985). Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial. Cancer Treat Rep, 69(9), 1029–1030.
Gockerman, J. P., M. Raney, and T. Logan. “Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial.” Cancer Treat Rep 69, no. 9 (September 1985): 1029–30.
Gockerman JP, Raney M, Logan T. Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial. Cancer Treat Rep. 1985 Sep;69(9):1029–30.
Gockerman, J. P., et al. “Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial.” Cancer Treat Rep, vol. 69, no. 9, Sept. 1985, pp. 1029–30.
Gockerman JP, Raney M, Logan T. Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial. Cancer Treat Rep. 1985 Sep;69(9):1029–1030.
Published In
Cancer Treat Rep
ISSN
0361-5960
Publication Date
September 1985
Volume
69
Issue
9
Start / End Page
1029 / 1030
Location
United States
Related Subject Headings
- Neutropenia
- Neoplasm Metastasis
- Nausea
- Naphthacenes
- Middle Aged
- Humans
- Female
- Drug Evaluation
- Breast Neoplasms
- Antibiotics, Antineoplastic